Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Vitamin D, Calcium and Phosphorus Status Involvement during COVID-19 Infection
Ali et al., Asian Journal of Research in Biochemistry, doi:10.9734/ajrb/2022/v11i2214
Ali et al., Vitamin D, Calcium and Phosphorus Status Involvement during COVID-19 Infection, Asian Journal of Research in Biochemistry, doi:10.9734/ajrb/2022/v11i2214
Dec 2022   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 50 hospitalized COVID-19 patients and 50 healthy controls, showing lower vitamin D levels in COVID-19 patients, and a negative correlation between vitamin D level and COVID-19 severity.
Ali et al., 8 Dec 2022, retrospective, Sudan, peer-reviewed, 5 authors, study period December 2021 - April 2022.
Contact: abdalla.ali2087@yahoo.com.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Abstract: Asian Journal of Research in Biochemistry Volume 11, Issue 2, Page 29-38, 2022; Article no.AJRB.94190 ISSN: 2582-0516 Vitamin D, Calcium and Phosphorus Status Involvement during COVID-19 Infection Abdalla Eltoum Ali a,b*, Mohamed Fathy Seyyed Ahmed a, Somia Mohammed Suliman b, Ibrahim Ahamed Ali Karti b and Haidar Eltayeb Saleh c a Department of Clinical Chemistry, Faculty of Medical Laboratory Sciences, University of Alzaeim Alazhari, Sudan. b Program of Medicine & Medical Laboratory Science, Alofoug College of Science & Technology, Khartoum, Sudan. c Clinical Research Laboratory Services, Sylvester Comprehensive Cancer Center (SCCC), Miami University, Miami Fl33136, USA. Authors’ contributions This work was carried out in collaboration among all authors. All authors read and approved the final manuscript. Article Information DOI: 10.9734/AJRB/2022/v11i2214 Open Peer Review History: This journal follows the Advanced Open Peer Review policy. Identity of the Reviewers, Editor(s) and additional Reviewers, peer review comments, different versions of the manuscript, comments of the editors, etc are available here: https://www.sdiarticle5.com/review-history/94190 Original Research Article Received: 27/09/2022 Accepted: 03/12/2022 Published: 08/12/2022 ABSTRACT Background: COVID-19 is associated with a weak immune system in the human body. Vitamin D plays a role in the body’s immune system and is known to enhance the function of immune cells. In this case, vitamin D inhibits some of the inflammation that can make COVID-19 more severe. The is study aims to determine the serum levels of vitamin D, calcium, and phosphorus in COVID-19 patients. Methods: This was a cross sectional study conducted during the period from January 2021 to July _____________________________________________________________________________________________________ *Corresponding author: E-mail: abdalla.ali2087@yahoo.com; Asian J. Res. Biochem., vol. 11, no. 2, pp. 29-38, 2022 Ali et al.; Asian J. Res. Biochem., vol. 11, no. 2, pp. 29-38, 2022; Article no.AJRB.94190 2021. 50 COVID-19 patients as a case study and 50 healthy individuals as a control group were included in this study. Blood samples were collected from the study group and measured for vitamin D using Enzyme-linked immunosorbent assay (ELISA) technique. Calcium and phosphate were measured by the Cobas 6000 fully automated analyzer (Roche, Germany). Results: The study result showed that in COVID-19 patients, vitamin D (27 ± 5 ng/mL), p-value = 0.000, and calcium (10.2 ± 4 mg/dL), p-value = 0.000, in comparison with control. There was a correlation between vitamin D (r = -.771; p =.000) and calcium (r = -.752; p =.000) and the severity of disease. Conclusions: According to our research, vitamin D deficiency may increase the risk of developing COVID-19 and the risk of developing severe illnesses. Keywords: COVID -19; vitamin D; calcium; phosphate.
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit